Immune Responses to ESAT-6 and CFP-10 by FASCIA and Multiplex Technology for Diagnosis of M. tuberculosis Infection; IP-10 Is a Promising Marker

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Borgström, Emilie ^a   Andersen, Peter ^b   Atterfelt, Fredrik ^c   Julander, Inger ^a   Källenius, Gunilla ^d   Maeurer, Markus ^e   Rosenkrands, Ida ^b   Widfeldt, Maria ^c   Bruchfeld, Judith ^a   Gaines, Hans ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DIAGNOSTIC ACCURACY; DISEASE MARKER; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; INNATE IMMUNITY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; PATIENT ASSESSMENT; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; SUPERNATANT; T LYMPHOBLAST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHEMOKINE CXCL10; CYTOKINES; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84869023628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043438     Document Type: Article

References (48)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
2. Pai M, Kalantri S, Dheda K, (2006) New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 6: 423-432.
3. Pai M, Minion J, Steingart K, Ramsay A, (2010) New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 16: 271-284.
4. Huebner RE, Schein MF, Bass JB Jr, (1993) The tuberculin skin test. Clin Infect Dis 17: 968-975.
5. Richeldi L, (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174: 736-742.
6. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017-2021.
7. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, et al. (2010) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 59: 1-25.
8. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, et al. (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33: 956-973.
9. Kabeer BS, Sikhamani R, Raja A, (2010) Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24: 323-325.
10. Butera O, Chiacchio T, Carrara S, Casetti R, Vanini V, et al. (2009) New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis 9: 182.
11. Kik SV, Franken WP, Mensen M, Cobelens FG, Kamphorst M, et al. (2010) Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 35: 1346-1353.
12. Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, et al. (2011) The tuberculin skin test versus QuantiFERON TB Gold(R) in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 6: e17984.
13. Rieder HL, Watson JM, Raviglione MC, Forssbohm M, Migliori GB, et al. (1996) Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases. Eur Respir J 9: 1097-1104.
14. Goletti D, Raja A, Syed Ahamed Kabeer B, Rodrigues C, Sodha A, et al. (2010) Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 5: e12577.
15. Sargentini V, Mariotti S, Carrara S, Gagliardi MC, Teloni R, et al. (2009) Cytometric detection of antigen-specific IFN-gamma/IL-2 secreting cells in the diagnosis of tuberculosis. BMC Infect Dis 9: 99.
16. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, et al. (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32: 1607-1615.
17. Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, et al. (2011) A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 91: 260-267.
18. Ruhwald M, Petersen J, Kofoed K, Nakaoka H, Cuevas LE, et al. (2008) Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10. PLoS One 3: e2858.
19. Biselli R, Mariotti S, Sargentini V, Sauzullo I, Lastilla M, et al. (2010) Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls. Clin Microbiol Infect 16: 1282-1284.
20. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO, (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39: 723-729.
21. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO, (2010) Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 5: e12365.
22. He XY, Xiao L, Chen HB, Hao J, Li J, et al. (2010) T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis 29: 643-650.
23. Gaines H, Andersson L, Biberfeld G, (1996) A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J Immunol Methods 195: 63-72.
24. Gaines H, Biberfeld G, (2000) Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol Biol 134: 243-255.
25. Lagrelius M, Jones P, Franck K, Gaines H, (2006) Cytokine detection by multiplex technology useful for assessing antigen specific cytokine profiles and kinetics in whole blood cultured up to seven days. Cytokine 33: 156-165.
26. Svahn A, Linde A, Thorstensson R, Karlen K, Andersson L, et al. (2003) Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 277: 17-25.
27. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
28. Juffermans NP, Verbon A, van Deventer SJ, van Deutekom H, Belisle JT, et al. (1999) Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 67: 4295-4297.
29. Lalor MK, Smith SG, Floyd S, Gorak-Stolinska P, Weir RE, et al. (2010) Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 28: 1635-1641.
30. Torrado E, Robinson RT, Cooper AM, (2011) Cellular response to mycobacteria: balancing protection and pathology. Trends Immunol 32: 66-72.
31. Borgstrom E, Andersen P, Andersson L, Julander I, Kallenius G, et al. (2011) Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection. J Immunol Methods 370: 55-64.
32. Dlugovitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, et al. (1997) Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol 18: 203-207.
33. Khader SA, Gopal R, (2010) IL-17 in protective immunity to intracellular pathogens. Virulence 1: 423-427.
34. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, et al. (2010) Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 184: 4414-4422.
35. Rahman S, Gudetta B, Fink J, Granath A, Ashenafi S, et al. (2009) Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions. Am J Pathol 174: 2211-2224.
36. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. (2007) CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59.
37. Chiacchio T, Petruccioli E, Vanini V, Butera O, Cuzzi G, et al. (2011) Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 6: e27539.
38. Syed Ahamed Kabeer B, Raman B, Thomas A, Perumal V, Raja A, (2010) Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 5: e9051.
39. Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, et al. (2005) IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7: 1-8.
40. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, et al. (2007) CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812.
41. Goletti D, Raja A, Ahamed Kabeer BS, Rodrigues C, Sodha A, et al. (2010) IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 61: 133-143.
42. Moser B, Loetscher P, (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128.
43. Liu M, Guo S, Hibbert JM, Jain V, Singh N, et al. (2011) CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 22: 121-130.
44. Kabeer BS, Raja A, Raman B, Thangaraj S, Leportier M, et al. (2011) IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 11: 135.
45. Farhat M, Greenaway C, Pai M, Menzies D, (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10: 1192-1204.
46. Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M, (2008) Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis 12: 498-505.
47. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, et al. (2010) Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.
48. Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, et al. (2006) Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8: 2052-2060.